Dutasteride: 21st Century medical therapy for symptomatic benign prostatic hyperplasia

Author： Shergill Iqbal S   Barua Jayanta M  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.3, 2006-05, pp. : 383-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benign Prostatic Hyperplasia: Pathogenesis and Medical Therapy

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 12, 1991-12 ,pp. : 1208-1216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of a fixed‐dose combination of dutasteride and tamsulosin treatment (Duodart®) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment‐naïve men with moderately symptomatic benign prostatic hyperplasia: 2‐year CONDUCT study results

By  

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 450-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Medical Therapy or Surgery on Prostatic and Bladder Resistive Indices in Patients with Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 94, Iss. 2, 2015-0 ,pp. : 181-186

Karger

Access to resources Recommend Favorite

Effect of Terazosin on the Lipid Profile in Patients with Symptomatic Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 67, Iss. 2, 2001-08 ,pp. : 156-159

Karger

Access to resources Recommend Favorite

A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasia

By  

BJU INTERNATIONAL, Vol. 81, Iss. S1, 1998-03 ,pp. : 56-63

John Wiley & Sons Inc

Access to resources Recommend Favorite